Release Date: 10/06/16 15:54 Summary: Results of Meeting-BRB.AX Price Sensitive: No Download Document 45.64KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%